182 related articles for article (PubMed ID: 277944)
1. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.
Drachman DB; Angus CW; Adams RN; Kao I
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3422-6. PubMed ID: 277944
[TBL] [Abstract][Full Text] [Related]
2. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.
Drachman DB; Angus CW; Adams RN; Michelson JD; Hoffman GJ
N Engl J Med; 1978 May; 298(20):1116-22. PubMed ID: 643030
[TBL] [Abstract][Full Text] [Related]
3. Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions.
Stanley EF; Drachman DB
Science; 1978 Jun; 200(4347):1285-7. PubMed ID: 663610
[TBL] [Abstract][Full Text] [Related]
4. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
Appel SH; Anwyl R; McAdams MW; Elias S
Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
[TBL] [Abstract][Full Text] [Related]
5. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation.
Kao I; Drachman DB
Science; 1977 Apr; 196(4289):527-9. PubMed ID: 850793
[TBL] [Abstract][Full Text] [Related]
6. Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture.
Bevan S; Kullberg RW; Heinemann SF
Nature; 1977 May; 267(5608):263-5. PubMed ID: 865619
[No Abstract] [Full Text] [Related]
7. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis.
Drachman DB; Adams RN; Josifek LF; Self SG
N Engl J Med; 1982 Sep; 307(13):769-75. PubMed ID: 7110241
[TBL] [Abstract][Full Text] [Related]
8. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate.
Tzartos SJ; Sophianos D; Zimmerman K; Starzinski-Powitz A
J Immunol; 1986 May; 136(9):3231-8. PubMed ID: 3958494
[TBL] [Abstract][Full Text] [Related]
9. Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis.
Lindstrom J; Einarson B
Muscle Nerve; 1979; 2(3):173-9. PubMed ID: 503104
[TBL] [Abstract][Full Text] [Related]
10. Modulation of acetylcholine receptor by antibody against the receptor.
Heinemann S; Bevan S; Kullberg R; Lindstrom J; Rice J
Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3090-4. PubMed ID: 268657
[TBL] [Abstract][Full Text] [Related]
11. Degradation of acetylcholine receptor in diaphragms of rats with experimental autoimmune myasthenia gravis.
Merlie JP; Heinemann S; Einarson B; Lindstrom JM
J Biol Chem; 1979 Jul; 254(14):6328-32. PubMed ID: 447717
[TBL] [Abstract][Full Text] [Related]
12. Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
Kaplan I; Blakely BT; Pavlath GK; Travis M; Blau HM
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8100-4. PubMed ID: 2236023
[TBL] [Abstract][Full Text] [Related]
13. Interaction of myasthenic serum globulin with the acetylcholine receptor.
Almon RR; Appel SH
Biochim Biophys Acta; 1975 May; 393(1):66-77. PubMed ID: 1138925
[TBL] [Abstract][Full Text] [Related]
14. Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle.
Reiness CG; Weinberg CB; Hall ZW
Nature; 1978 Jul; 274(5666):68-70. PubMed ID: 661996
[No Abstract] [Full Text] [Related]
15. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
[TBL] [Abstract][Full Text] [Related]
16. 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
Kuncl RW; Drachman DB; Adams R; Lehar M
J Pharmacol Exp Ther; 1993 Nov; 267(2):582-9. PubMed ID: 8246131
[TBL] [Abstract][Full Text] [Related]
17. Myasthenic globulin enhances the loss of acetylcholine receptor clusters.
Bursztajn S; McManaman JL; Elias SB; Appel SH
Science; 1983 Jan; 219(4581):195-7. PubMed ID: 6849132
[TBL] [Abstract][Full Text] [Related]
18. Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors.
Fulpius BW; Miskin R; Reich E
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4326-30. PubMed ID: 6933485
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis. Identification of skeletal and heart muscle antigens not related to the acetylcholine receptor.
Mehl VS; Lang RW
J Neuroimmunol; 1984 Aug; 6(5):347-60. PubMed ID: 6205020
[TBL] [Abstract][Full Text] [Related]
20. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
[No Abstract] [Full Text] [Related]
[Next] [New Search]
